HRP20100484T1 - Ptičja telomeraza koja je reverzna transkriptaza - Google Patents
Ptičja telomeraza koja je reverzna transkriptaza Download PDFInfo
- Publication number
- HRP20100484T1 HRP20100484T1 HR20100484T HRP20100484T HRP20100484T1 HR P20100484 T1 HRP20100484 T1 HR P20100484T1 HR 20100484 T HR20100484 T HR 20100484T HR P20100484 T HRP20100484 T HR P20100484T HR P20100484 T1 HRP20100484 T1 HR P20100484T1
- Authority
- HR
- Croatia
- Prior art keywords
- selection marker
- nucleic acid
- vector
- cell
- acid molecule
- Prior art date
Links
- 108010017842 Telomerase Proteins 0.000 title claims abstract 3
- 241000271566 Aves Species 0.000 title claims 11
- 102100032938 Telomerase reverse transcriptase Human genes 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 claims abstract 14
- 108020004707 nucleic acids Proteins 0.000 claims abstract 11
- 102000039446 nucleic acids Human genes 0.000 claims abstract 11
- 239000000126 substance Substances 0.000 claims abstract 4
- 239000003550 marker Substances 0.000 claims 18
- 238000000034 method Methods 0.000 claims 8
- 241000700605 Viruses Species 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 5
- 241000272834 Cairina moschata Species 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 230000010261 cell growth Effects 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 241000272525 Anas platyrhynchos Species 0.000 claims 2
- 241000272521 Anatidae Species 0.000 claims 2
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 241000701161 unidentified adenovirus Species 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 241000710929 Alphavirus Species 0.000 claims 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims 1
- 241000714192 Human spumaretrovirus Species 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 102100034343 Integrase Human genes 0.000 claims 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 claims 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 102000015696 Interleukins Human genes 0.000 claims 1
- 108010063738 Interleukins Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims 1
- -1 antibodies Substances 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 239000003114 blood coagulation factor Substances 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000003630 growth substance Substances 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 229940047124 interferons Drugs 0.000 claims 1
- 229940047122 interleukins Drugs 0.000 claims 1
- 230000010076 replication Effects 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Izolirani ili rekombinantni polipeptid, naznačen time da sadrži aminokiselinsku sekvenciju koja ima najmanje 80% aminokiselinske sekvencije identične aminokiselinskoj sekvenciji SEQ ID N°: 1 telomeraze Cairina moschata koja djeluje kao reverzna transkiptaza, te koja ima TERT aktivnost. Patent sadrži još 26 patentnih zahtjeva.
Claims (27)
1. Izolirani ili rekombinantni polipeptid, naznačen time da sadrži aminokiselinsku sekvenciju koja ima najmanje 80% aminokiselinske sekvencije identične aminokiselinskoj sekvenciji SEQ ID N°: 1 telomeraze Cairina moschata koja djeluje kao reverzna transkiptaza, te koja ima TERT aktivnost.
2. Izolirana ili rekombinantna molekula nukleinske kiseline, naznačena time da kodira polipeptid prema patentnom zahtjevu 1.
3. Izolirana ili rekombinantna molekula nukleinske kiseline prema patentnom zahtjevu 2, naznačena time da molekula nukleinske kiseline sadrži sekvenciju nukleinske kiseline koja je najmanje 90% identična sekvenciji nukleinske kiseline SEQ ID N°: 2.
4. Vektor koji nosi izoliranu ili rekombinantnu molekulu nukleinske kiselinu, naznačen time da je prema bilo kojem od patentnih zahtjeva 2 ili 3.
5. Vektor prema patentnom zahtjevu 4, naznačen time da rečeni vektor sadrži dvije sekvencije homologne ciljanoj sekvenciji DNA.
6. Vektor prema patentnom zahtjevu 5, naznačen time da je rečena molekula nukleinske kiseline okružena rečenom homolognom sekvencijom.
7. Vektor prema bilo kojem od patentnih zahtjeva 5 do 6, naznačen time da rečeni vektor nadalje sadrži prvi selekcijski biljeg, pri čemu prvi selekcijski biljeg jest pozitivni selekcijski biljeg, te pri čemu je rečeni prvi selekcijski biljeg okružen rečenom homolognom sekvencijom.
8. Vektor prema patentnom zahtjevu 7, naznačen time da je rečeni prvi selekcijski biljeg okružen sekvencijom koja dozvoljava supresiju.
9. Vektor prema bilo kojem od patentnih zahtjeva 5 do 8, naznačen time da rečeni vektor sadrži drugi selekcijski biljeg koji nije okružen rečenom homolognom sekvencijom te pri čemu je rečeni selekcijski biljeg negativni selekcijski biljeg.
10. Vektor prema bilo kojem od patentnih zahtjeva 7 do 9, naznačen time da rečeni vektor sadrži treći selekcijski biljeg pri čemu je treći selekcijski biljeg negativni selekcijski biljeg, te pri čemu je rečeni treći selekcijski biljeg smješten između sekvencija koje dozvoljavaju supresiju prvog selekcijski biljega.
11. Ptičja stanica, naznačen time da je transfecirana molekulom nukleinske kiseline prema bilo kojem od patentnih zahtjeva 2 ili 3.
12. Ptičja stanica prema patentnom zahtjevu 11, naznačena time da je rečena molekula nukleinske kiseline insertirana u HPRT gen rečene ptičje stanice.
13. Ptičja stanica prema bilo kojem od patentnih zahtjeva 11 do 12, naznačena time da je rečena ptičja stanica izvedena od životinja koja pripadaju obitelji Anatidae, preferirano vrstama Cairina moschata ili Anas platyrhynchos.
14. Ptičja stanica prema bilo kojem od patentnih zahtjeva 11 do 13, naznačena time da nadalje sadrži sekvneciju nukleinske kiseline koja kodira tvar od interesa.
15. Ptičja stanica prema bilo kojem od patentnih zahtjeva 11 do 14, naznačena time da nadalje sadrži komplementacijsku kazetu koja dozvoljava propagaciju defektivnog virusa.
16. Upotreba polipeptida prema patentnom zahtjevu 1, molekule nukleinske kiseline prema bilo kojem od patentnih zahtjeva 2 ili 3 ili vektora prema bilo kojem od patentnih zahtjeva 4 do 10, naznačena time da je za imortalizaciju ptičje stanice.
17. Upotreba ptičje stanice prema bilo kojem od patentnih zahtjeva 1 do 14, naznačena time da je za replikaciju živog, umrtvljenog ili rekombinantnog virusa, preferirano odabranog iz skupine koju čine: poksovirus, adenovirus, retrovirus, herpesvirus, alfavirus, pjenasti virus te adenovirusom povezani virus.
18. Upotreba ptičje stanice prema patentnom zahtjevu 17, naznačena time da je poksovirus virus za vakcinu, a posebice modificirani virus za vakcinu Ankara (MVA) virus.
19. Upotreba ptičje stanice prema patentnom zahtjevu 14, naznačena time da je za produkciju tvari od interesa.
20. Upotreba ptičje stanice prema patentnom zahtjevu 19, naznačena time da je rečena tvar od interesa odabrana iz sljedeće skupine: faktori rasta, regulatori rasta, antitijela, antigeni, interleukini, inzulin, G-CSF, GM-CSF, hPG-CSF, M-CSF, interferoni, faktori zgrušavanja krvi te njihova kombinacija.
21. Postupak imortalizacije ptičje stanice, naznačen time da obuhvaća korak transfekcije vektora u rečenu stanicu prema bilo kojem od patentnih zahtjeva 4 do 10.
22. Postupak prema patentnom zahtjevu 21, naznačen time da dalje obuhvaća korak u kojem je rečena ptičja stanica kultivirana u mediju koji dozvoljava samo rast stanica u koje je ugrađen prvi selekcijski biljeg.
23. Postupak prema bilo kojem od patentnih zahtjeva 21 do 22, naznačen time da dalje obuhvaća korak u kojem je rečena ptičja stanica kultivirana u mediju koji ne dozvoljava rast stanica u koje je ugrađen drugi selekcijski biljeg.
24. Postupak prema bilo kojem od patentnih zahtjeva 21 do 23, naznačen time da rečeni postupak nadalje obuhvaća korak koji se sastoji od isključivanja prvog selekcijskog biljega iz genoma rečena ptičje stanice.
25. Postupak prema patentnom zahtjevu 24, naznačen time da ptičje stanice, dobivene nakon rečenog koraka isključivanja prvog selekcijski biljeg iz genoma rečenih ptičjih stanica, jesu kultivirane u mediju koji ne dozvoljava rast stanice koje sadrže treći selekcijski biljeg.
26. Postupak prema bilo kojem od patentnih zahtjeva 21 do 25, naznačen time da je rečena ptičja stanica uzeta od organizma koji pripada obitelji Anatidae, preferirano vrsti Cairina moschata ili Anas platyrhynchos.
27. Postupak prema bilo kojem od patentnih zahtjeva 21 do 26, naznačen time da je rečena molekula nukleinske kiseline insertirana u ciljani DNA sekvenciju rečene stanice, preferirano u HPRT gen.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06360001 | 2006-01-05 | ||
| EP06360047 | 2006-10-13 | ||
| PCT/EP2007/050120 WO2007077256A1 (en) | 2006-01-05 | 2007-01-05 | Avian telomerase reverse transcriptase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100484T1 true HRP20100484T1 (hr) | 2010-10-31 |
Family
ID=38016619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100484T HRP20100484T1 (hr) | 2006-01-05 | 2010-09-03 | Ptičja telomeraza koja je reverzna transkriptaza |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US9024003B2 (hr) |
| EP (1) | EP1979474B1 (hr) |
| JP (2) | JP5661243B2 (hr) |
| KR (1) | KR101337377B1 (hr) |
| CN (1) | CN102268413A (hr) |
| AT (1) | ATE477321T1 (hr) |
| AU (1) | AU2007204024B2 (hr) |
| BR (1) | BRPI0706836B1 (hr) |
| CA (1) | CA2636329C (hr) |
| CY (1) | CY1110860T1 (hr) |
| DE (1) | DE602007008360D1 (hr) |
| DK (1) | DK1979474T3 (hr) |
| HK (1) | HK1122069A1 (hr) |
| HR (1) | HRP20100484T1 (hr) |
| PL (1) | PL1979474T3 (hr) |
| PT (1) | PT1979474E (hr) |
| RS (1) | RS51525B (hr) |
| RU (1) | RU2415867C2 (hr) |
| SI (1) | SI1979474T1 (hr) |
| WO (1) | WO2007077256A1 (hr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9024003B2 (en) * | 2006-01-05 | 2015-05-05 | Transgene S.A. | Avian telomerase reverse transcriptase |
| EP1985305A1 (en) * | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
| US8357531B2 (en) * | 2007-07-03 | 2013-01-22 | Transgene S.A. | Immortalized avian cell lines |
| KR101014030B1 (ko) | 2008-08-29 | 2011-02-14 | 현대자동차주식회사 | 와이어링 취부용 플랜지 및 제조공정 |
| JP5855564B2 (ja) * | 2009-05-12 | 2016-02-09 | トランジェーヌ、ソシエテ、アノニムＴｒａｎｓｇｅｎｅ Ｓ．Ａ． | オルソポックスウイルスの製造および精製方法 |
| US20120309056A1 (en) | 2010-02-04 | 2012-12-06 | Leon Arnaud | Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
| WO2012095514A1 (en) | 2011-01-14 | 2012-07-19 | Vivalis | Recombinant protein production system |
| JP2014518080A (ja) | 2011-06-27 | 2014-07-28 | バルネバ | 細胞のスクリーニング方法 |
| WO2013045658A1 (en) | 2011-09-29 | 2013-04-04 | Transgene Sa | Immunotherapy composition and regimen for treating hepatitis c virus infection |
| TW201321016A (zh) | 2011-09-29 | 2013-06-01 | Transgene Sa | 免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（二） |
| DK3226894T3 (da) | 2014-12-01 | 2019-10-21 | Transgene Sa | Stabile flydende vacciniavirus-formuleringer |
| JP6546659B2 (ja) * | 2014-12-04 | 2019-07-17 | インターベット インターナショナル ベー． フェー． | 不死化ニワトリ胚線維芽細胞 |
| US20190134190A1 (en) | 2016-05-04 | 2019-05-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
| EP3522920A2 (en) | 2016-10-10 | 2019-08-14 | Transgene SA | Immunotherapeutic product and mdsc modulator combination therapy |
| US11306292B2 (en) | 2017-05-15 | 2022-04-19 | Janssen Vaccines & Prevention B.V. | Stable virus-containing composition |
| WO2018211419A1 (en) | 2017-05-15 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Stable virus-containing composition |
| SG11201912429RA (en) | 2017-06-21 | 2020-01-30 | Transgene Sa | Personalized vaccine |
| WO2019014652A1 (en) * | 2017-07-13 | 2019-01-17 | Memphis Meats, Inc. | COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CELL CULTURES USED IN FOOD PRODUCTION |
| JP7437385B2 (ja) | 2018-09-06 | 2024-02-22 | バヴァリアン・ノルディック・アクティーゼルスカブ | 保管が改善されたポックスウイルス組成物 |
| FR3089789B1 (fr) | 2018-12-14 | 2022-05-27 | Univ Claude Bernard Lyon | Production de vaccins viraux sur une lignee cellulaire aviaire |
| EP3842065A1 (en) | 2019-12-23 | 2021-06-30 | Transgene | Process for designing a recombinant poxvirus for a therapeutic vaccine |
| AU2021233167A1 (en) | 2020-03-12 | 2022-09-22 | Bavarian Nordic A/S | Compositions improving poxvirus stability |
| JP2023533584A (ja) | 2020-07-13 | 2023-08-03 | トランジェーヌ | 免疫低下の処置 |
| WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002300900A (ja) | 2001-04-05 | 2002-10-15 | National Institute Of Advanced Industrial & Technology | 腫瘍悪性化因子および腫瘍悪性化を抑制する化合物のスクリーニング方法 |
| US20050084959A1 (en) | 2001-10-31 | 2005-04-21 | Hirofumi Hamada | Immortalized mesenchymal cells and utilization thereof |
| JP3897717B2 (ja) * | 2002-04-23 | 2007-03-28 | オリンパス株式会社 | 細胞移植治療材料およびその製造方法 |
| US9024003B2 (en) * | 2006-01-05 | 2015-05-05 | Transgene S.A. | Avian telomerase reverse transcriptase |
-
2007
- 2007-01-05 US US12/159,930 patent/US9024003B2/en active Active
- 2007-01-05 JP JP2008549016A patent/JP5661243B2/ja active Active
- 2007-01-05 EP EP07703676A patent/EP1979474B1/en active Active
- 2007-01-05 RU RU2008125815/10A patent/RU2415867C2/ru active
- 2007-01-05 WO PCT/EP2007/050120 patent/WO2007077256A1/en active Application Filing
- 2007-01-05 DK DK07703676.2T patent/DK1979474T3/da active
- 2007-01-05 AT AT07703676T patent/ATE477321T1/de active
- 2007-01-05 PT PT07703676T patent/PT1979474E/pt unknown
- 2007-01-05 SI SI200730331T patent/SI1979474T1/sl unknown
- 2007-01-05 DE DE602007008360T patent/DE602007008360D1/de active Active
- 2007-01-05 PL PL07703676T patent/PL1979474T3/pl unknown
- 2007-01-05 RS RSP-2010/0470A patent/RS51525B/en unknown
- 2007-01-05 BR BRPI0706836-0A patent/BRPI0706836B1/pt not_active IP Right Cessation
- 2007-01-05 CN CN201110186565XA patent/CN102268413A/zh active Pending
- 2007-01-05 AU AU2007204024A patent/AU2007204024B2/en not_active Ceased
- 2007-01-05 KR KR1020087018929A patent/KR101337377B1/ko active IP Right Grant
- 2007-01-05 CA CA2636329A patent/CA2636329C/en active Active
-
2009
- 2009-03-17 HK HK09102511.7A patent/HK1122069A1/xx not_active IP Right Cessation
-
2010
- 2010-09-03 HR HR20100484T patent/HRP20100484T1/hr unknown
- 2010-10-27 CY CY20101100971T patent/CY1110860T1/el unknown
-
2012
- 2012-09-10 JP JP2012198723A patent/JP2013027397A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080085074A (ko) | 2008-09-22 |
| EP1979474A1 (en) | 2008-10-15 |
| DE602007008360D1 (de) | 2010-09-23 |
| RS51525B (en) | 2011-06-30 |
| SI1979474T1 (sl) | 2010-10-29 |
| RU2415867C2 (ru) | 2011-04-10 |
| KR101337377B1 (ko) | 2013-12-09 |
| RU2008125815A (ru) | 2010-02-10 |
| JP5661243B2 (ja) | 2015-01-28 |
| HK1122069A1 (en) | 2009-05-08 |
| ATE477321T1 (de) | 2010-08-15 |
| PL1979474T3 (pl) | 2011-01-31 |
| JP2013027397A (ja) | 2013-02-07 |
| AU2007204024A1 (en) | 2007-07-12 |
| BRPI0706836A2 (pt) | 2011-04-05 |
| CA2636329A1 (en) | 2007-07-12 |
| JP2009521945A (ja) | 2009-06-11 |
| US20100173378A1 (en) | 2010-07-08 |
| DK1979474T3 (da) | 2010-09-20 |
| WO2007077256B1 (en) | 2007-10-25 |
| BRPI0706836B1 (pt) | 2021-05-25 |
| WO2007077256A1 (en) | 2007-07-12 |
| CN102268413A (zh) | 2011-12-07 |
| CY1110860T1 (el) | 2015-06-10 |
| US9024003B2 (en) | 2015-05-05 |
| AU2007204024B2 (en) | 2012-01-19 |
| PT1979474E (pt) | 2010-10-22 |
| EP1979474B1 (en) | 2010-08-11 |
| CA2636329C (en) | 2016-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20100484T1 (hr) | Ptičja telomeraza koja je reverzna transkriptaza | |
| JP7084565B2 (ja) | Ｒｎａの安定化のための３’ｕｔｒ配列 | |
| US10729784B2 (en) | Method for cellular RNA expression | |
| RU2010102668A (ru) | Иммортализованная клеточная линия птиц | |
| HRP20190652T1 (hr) | Fuzijski proteini od prirodnih ljudskih proteinskih fragmenata za proizvodnju pravilno multimeriziranih fc-sastava imunoglobulina | |
| JP6131433B2 (ja) | 細胞ｒｎａ発現のための方法 | |
| HRP20211468T1 (hr) | Postupci i pripravci za nukleazno posredovani inženjering genoma i ispravak u krvotvornim matičnim stanicama | |
| RU2753884C2 (ru) | Промоторы для усиления экспрессии в поксвирусах | |
| JP2012070744A (ja) | 哺乳類βアクチンプロモーターを利用した発現系 | |
| Jordan et al. | A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium | |
| CN108473978A (zh) | 经过改良的副粘病毒载体 | |
| Yang et al. | Molecular cloning and expression analysis of TRAF3 in chicken | |
| Ruetz et al. | In vitro and in vivo CRISPR-Cas9 screens reveal drivers of aging in neural stem cells of the brain | |
| Laidlaw et al. | Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon | |
| CN1289682C (zh) | 通过使用牛痘ati启动子表达改良的安卡拉痘苗病毒中的基因 | |
| EP2917350B1 (en) | Method for cellular rna expression | |
| KR20200066748A (ko) | 바이러스 벡터, 세포 및 작제물 | |
| RU2014129220A (ru) | Новый аттенуированный полиовирус: pv-1 mono-cre-x | |
| ES2349483T3 (es) | Transcriptasa inversa de la telomerasa aviar. | |
| KR20220149476A (ko) | 바이러스 백신 생산용 조류 세포 제조용 조성물 및 바이러스 저항성 조류 세포 제조용 조성물 | |
| Buttigieg et al. | Construction of FWPV Chimaeric MVA | |
| Zhang | Vaccinia virus BTB-Kelch proteins | |
| KR20200056937A (ko) | 세포의 dna에 시간의 흐름을 기록하는 방법 | |
| Rutishauser | Blimp-1 regulates the terminal differentiation of effector and memory CD8 T cells |